TxCell S.A. - Ownership and Business Overview

Life ScienceCompany

TxCell S.A. Ownership

Who owns TxCell S.A.?

TxCell S.A. is owned by Sangamo Therapeutics. It was acquired on July 23, 2018.

TxCell S.A. Business Overview

Where is TxCell S.A. headquartered?

TxCell S.A. is headquartered in Valbonne, France.

What is TxCell S.A.’s revenue?

TxCell S.A. disclosed revenue of 2M EUR for 2017 and 3M EUR for 2016.

How many employees does TxCell S.A. have?

TxCell S.A. has 41 employees.

What sector is TxCell S.A. in?

TxCell S.A. is a life science company.

When was TxCell S.A. founded?

TxCell S.A. was founded in 2001.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 247 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 202 by strategics.

TxCell S.A.

Allee de la Nertieere Les Cardoulines HT1 Sophia Antipolis,
Valbonne, 06560
France,
+ 33 4 97 21 83 00
www.txcell.com

TxCell S.A. is a biotechnology company that develops platforms for innovative, personalized T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases with high unmet medical need. TxCell is targeting transplantation as well as a range of autoimmune diseases (both T-cell and B-cell-mediated), such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases or inflammatory skin diseases.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for TxCell S.A.

Life Science Companies , France Companies